Condition
Primary Immune Deficiencies
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Completed1
Not Yet Recruiting1
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT01222741Recruiting
Studies of Disorders With Increased Susceptibility to Fungal Infections
NCT07526714Not Yet RecruitingPrimary
Longitudinal Prognosis of Lymphoproliferative Manifestations in Primary Immunodeficiencies
NCT02909244CompletedPrimary
Study of Gut Microbiota in Primary Immune Deficiency, Possibly Associated With Inflammatory Bowel Disease
NCT01981785UnknownPrimary
Investigation of Immune Disorders and Deficiencies
Showing all 4 trials